Parenteral Nutrition Market Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Nutrient Type (Single Dose Amino Acid Solution, Parenteral Lipid Emulsion, Carbohydrates, Trace Elements, and Vitamins and Minerals), and End User (Hospitals, Clinics, and Others) and Geography

The parenteral nutrition market size is projected to reach US$ 11.12 billion by 2030 from US$ 6.84 billion in 2022. The market is expected to register a CAGR of 6.0% during 2022–2030. Innovation in the formulation of nutrition products will likely remain a key trend in the market.

Parenteral Nutrition Market Analysis

The rising prevalence of gastrointestinal diseases and surge in cases of malnutrition and premature births and are the key driving factors behind the market development. Furthermore, the innovation in formulations of nutrition products is a crucial opportunity for the parenteral nutrition market players.

Parenteral Nutrition Market Overview

Crohn’s disease, bowel obstruction, ulcerative colitis, short bowel syndrome, microscopic colitis, and gastric cancer are a few examples of gastrointestinal diseases. According to the “Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study,” published in January 2021, functional gastrointestinal disorders have affected over 40% of people across the globe. Based on the Global Burden of Disease Study 2019, ~4.9 million cases of inflammatory bowel disease (IBD) were recorded worldwide in 2019. China (911,405) and the US (762,890) registered the highest number of cases, with prevalence of 66.9 and 245.3 cases per 100,000 people, respectively. Ulcerative colitis and Crohn’s disease are two of the commonly diagnosed IBDs. Crohn’s disease is a complex, chronic disorder primarily affecting the digestive system. It is the most common disease in North America and Europe.

Parenteral Nutrition Market Drivers and Opportunities

Surge in Cases of Malnutrition and Premature Births

Malnutrition includes being undernourished, overweight or obese, having inadequate vitamins or minerals, and having a non-communicable disease due to a bad diet. As per World Health Organization (WHO) data, ~1.9 billion adults were overweight or obese, whereas 462 million were underweight in 2021. Additionally, 39 million children under the age of 5 were overweight, 149 million had stunted growth and development as a result of a chronic lack of nutrient-rich food in their diets, and 45 million were wasted (too thin for height). Furthermore, ~45% of deaths among children aged less than 5 are associated with undernutrition. As per the July 2022 data of the United Nations International Children's Emergency Fund (UNICEF), the prevalence of undernourishment reached 9.3% in 2020 from 8.0% in 2019; it further jumped to 9.8% in 2021.

New Product Developments by Companies

Companies operating in the parenteral medical nutrition market constantly focus on new product launches, which help them improve their sales. A few of the noteworthy developments in the parenteral nutrition market are mentioned below:

• In December 2022, Baxter International Inc introduced the ExactaMix Pro Automated Compounder in the US. The announcement was made at the 2022 Midyear Clinical Meeting of the American Society of Health-System Pharmacists (ASHP). The product debuted at the beginning of 2023. The recently released product makes use of cutting-edge compounding technology to enhance patient safety, process effectiveness, and formulation accuracy.
• In March 2022, Fresenius Kabi’s SMOFlipid lipid injectable emulsion received US Food and Drug Administration (FDA) approval. The emulsion is used to provide parenteral nutrition to pediatric patients, including term and preterm neonates, which makes it the first and only four-oil lipid emulsion for pediatric patients requiring parenteral nutrition.

Thus, new product development of nutrition is anticipated to create opportunities for the market growth during the forecast period.

Parenteral Nutrition Market Report Segmentation Analysis

Key segments that contributed to the derivation of the parenteral nutrition market analysis are offerings, usage, and end user.

• Based on nutrient type, the parenteral nutrition market is segmented into single-dose amino acid solutions, parenteral lipid emulsion, carbohydrates, trace elements, vitamins and minerals. The single dose amino acid solution segment held a most significant market share in 2022.
• Based on end users, the parenteral nutrition market is segmented by hospitals, clinics, others. The hospitals segment held a largest market share in 2022.

Parenteral Nutrition Market Share Analysis by Geography

The geographic scope of the parenteral nutrition market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

In North America, the US parenteral nutrition market holds the largest share of the region. Cancer, heart disease, and other chronic diseases are the major causes of disability and death in the US. Per the National Center for Chronic Disease Prevention and Health Promotion, 6 in 10 people in the country are diagnosed with at least one chronic disease. Additionally, the American Hospital Association estimates that ~133 million people have at least one chronic disease, and that number is expected to reach 170 million by 2030. According to an article titled “Trends in Parenteral Nutrition,” published in January 2019; on average, ~34,000 patients receive parenteral nutrition (PN) annually in the US. Enteral tube feeding can be prescribed for treating more than 350 disease conditions in children.

Parenteral Nutrition Market Regional Insights

The regional trends and factors influencing the Parenteral Nutrition Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Parenteral Nutrition Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Parenteral Nutrition Market Report Scope

Parenteral Nutrition Market Players Density: Understanding Its Impact on Business Dynamics

The Parenteral Nutrition Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

Major Companies operating in the Parenteral Nutrition Market are:

1. ICU Medical Inc
2. Grifols SA
3. Pfizer Inc
4. Otsuka Pharmaceuticals Co Ltd
5. Baxter International Inc
6. B Braun SE

Disclaimer: The companies listed above are not ranked in any particular order.

Parenteral Nutrition Market News and Recent Developments

The Parenteral Nutrition Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the parenteral nutrition market are listed below:

• Baxter International Inc. received U.S. FDA approval of an expanded indication for Clinolipid (Lipid Injectable Emulsion) to be used in pediatric patients, including preterm and term neonates. Clinolipid is Baxter’s proprietary mixed oil lipid emulsion that is used to provide calories and essential fatty acids in parenteral (intravenous) nutrition (PN) when oral or enteral nutrition is not possible, insufficient or contraindicated. Clinolipid has been available in the U.S. for adults since 2019 and is now available for use in all ages. (Source: Baxter International Inc., Company Website, January 2020)

Parenteral Nutrition Market Report Coverage and Deliverables

The “Parenteral Nutrition Market Size and Forecast (2020–2030)” report provides a detailed analysis of the market covering below areas:

• Parenteral nutrition market  size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Parenteral nutrition market  trends as well as market dynamics such as drivers, restraints, and key opportunities
• Detailed PEST/Porter’s Five Forces and SWOT analysis
• Parenteral nutrition market  analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments.
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the parenteral nutrition market
• Detailed company profiles

The List of Companies - Parenteral Nutrition Market

1. ICU Medical Inc   
2. Grifols SA               
3. Pfizer Inc                
4. Otsuka Pharmaceuticals Co Ltd
5. Baxter International Inc   
6. B Braun SE             
7. Fresenius Kabi AG              
8. Sichuan Kelun-Biotech Biopharmaceutical Co Ltd  
9. Vifor Pharma Management AG
10. Aculife Healthcare Pvt Ltd            

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the parenteral nutrition market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the global parenteral nutrition market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth global parenteral nutrition market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.